LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
By Ben Glickman LianBio has received an unsolicited buyout offer from Concentra Biosciences, which is owned by LianBio minority shareholder Tang Capital. The.
CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ On November 22, 2023, the board of directors of Theseus Pharmaceuticals, Inc. received an unsolicited joint letter from funds and persons.
16.10.2023 - NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) - Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of .